• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性生殖系统肿瘤病理学,包括分子病理学。

Pathology of cancers of the female genital tract including molecular pathology.

机构信息

Department of Pathology, Autonomous University of Barcelona, Barcelona, Spain.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St Louis, MO, USA.

出版信息

Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:93-108. doi: 10.1002/ijgo.12617.

DOI:10.1002/ijgo.12617
PMID:30306579
Abstract

To better understand pathology reports, gynecologic oncologists must be familiar with the terminology used in gynecologic pathology. This chapter of the FIGO Cancer Report 2018 summarizes the clinical and pathological features of the most common cancers of the female genital tract, as well as their main molecular genetic alterations. In selected cases, an approach for processing surgical specimens is also included.

摘要

为了更好地理解病理报告,妇科肿瘤学家必须熟悉妇科病理学中使用的术语。2018 年 FIGO 癌症报告的这一章总结了女性生殖系统最常见癌症的临床和病理特征,以及它们的主要分子遗传学改变。在一些选定的情况下,还包括处理手术标本的方法。

相似文献

1
Pathology of cancers of the female genital tract including molecular pathology.女性生殖系统肿瘤病理学,包括分子病理学。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:93-108. doi: 10.1002/ijgo.12617.
2
Bibliography. Current world literature. Gynecologic oncology and pathology.参考文献。当代世界文献。妇科肿瘤学与病理学。
Curr Opin Obstet Gynecol. 1999 Feb;11(1):87-112.
3
Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy.妇科肿瘤学中的玻片复查可确保报告的完整性和诊断准确性。
Gynecol Oncol. 2003 Aug;90(2):425-30. doi: 10.1016/s0090-8258(03)00323-8.
4
Progress in surgical oncology: Gynecology perspective.外科肿瘤学进展:妇科视角。
J Surg Oncol. 2022 Oct;126(5):902-905. doi: 10.1002/jso.27036.
5
Value of Specialist Pathology Review in a Single Statewide Gynecologic Cancer Service.单一全州范围妇科癌症服务中专科病理学审查的价值
Int J Gynecol Cancer. 2017 Jan;27(1):171-176. doi: 10.1097/IGC.0000000000000834.
6
[Multiple cancers in gynecologic oncology].[妇科肿瘤学中的多种癌症]
Geburtshilfe Frauenheilkd. 1988 Oct;48(10):710-4. doi: 10.1055/s-2008-1026614.
7
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics.妇科癌症的国际妇产科联盟(FIGO)分期。1994 - 1997年FIGO妇科肿瘤学委员会。国际妇产科联盟。
Int J Gynaecol Obstet. 1999 Jun;65(3):243-9. doi: 10.1016/s0020-7292(99)00070-3.
8
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.日本妇产科学会妇科肿瘤学委员会年度报告
J Obstet Gynaecol Res. 2015 Dec;41(12):1861-9. doi: 10.1111/jog.12833. Epub 2015 Sep 30.
9
Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice.提高妇科肿瘤护理质量并降低成本。妇科肿瘤学会临床实践建议。
Gynecol Oncol. 2015 May;137(2):280-4. doi: 10.1016/j.ygyno.2015.02.021. Epub 2015 Feb 28.
10
Ten problematical issues identified by pathology review for multidisciplinary gynaecological oncology meetings.病理审查为妇科肿瘤多学科会议发现的 10 个问题。
J Clin Pathol. 2012 Apr;65(4):293-301. doi: 10.1136/jclinpath-2011-200352. Epub 2011 Oct 19.

引用本文的文献

1
Nanocarrier drug delivery systems for gynecological cancer therapeutics.用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
2
Clinicopathological and Molecular Characterization of Non-Endometrioid Endometrial Carcinoma.非子宫内膜样子宫内膜癌的临床病理及分子特征
J Cancer. 2025 Mar 31;16(7):2312-2320. doi: 10.7150/jca.108685. eCollection 2025.
3
Utility of ER, p53, CEA and Napsin A in Histological Subtyping of Endometrial Carcinoma and Their Correlation with Clinicopathological Prognostic Parameters: Experience from a Referral Institute.
雌激素受体、p53、癌胚抗原和 napsin A 在子宫内膜癌组织学亚型分类中的应用及其与临床病理预后参数的相关性:来自一家转诊机构的经验
Iran J Pathol. 2024 Spring;19(2):236-243. doi: 10.30699/IJP.2024.2008693.3154. Epub 2024 Jan 29.
4
Ovarian cancer ascites proteomic profile reflects metabolic changes during disease progression.卵巢癌腹水蛋白质组学图谱反映疾病进展过程中的代谢变化。
Biochem Biophys Rep. 2024 Jun 13;39:101755. doi: 10.1016/j.bbrep.2024.101755. eCollection 2024 Sep.
5
Clinical significance of TROAP in endometrial cancer and the antiproliferative and proapoptotic effects of TROAP knockdown in endometrial cancer cells: integrated utilization of bioinformatic analysis and in vitro test verification.TROAP 在子宫内膜癌中的临床意义及 TROAP 敲低对子宫内膜癌细胞的抗增殖和促凋亡作用:生物信息学分析与体外试验验证的综合利用。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):10049-10059. doi: 10.1007/s00210-024-03260-y. Epub 2024 Jul 5.
6
Modern Subtype Classification and Outlier Detection Using the Attention Embedder to Transform Ovarian Cancer Diagnosis.利用注意力嵌入对卵巢癌诊断进行转换,实现现代亚型分类和异常值检测。
Tomography. 2024 Jan 15;10(1):105-132. doi: 10.3390/tomography10010010.
7
Effusion cytology of metastatic carcinosarcoma.转移性癌肉瘤的积液细胞学检查
Cytojournal. 2023 Jun 8;20:14. doi: 10.25259/Cytojournal_30_2022. eCollection 2023.
8
SPON1 is an independent prognostic biomarker for ovarian cancer.SPON1 是卵巢癌的独立预后生物标志物。
J Ovarian Res. 2023 May 13;16(1):95. doi: 10.1186/s13048-023-01180-8.
9
Detection and Genotyping of Human Papillomavirus (HPV16/18), Epstein-Barr Virus (EBV), and Human Cytomegalovirus (HCMV) in Endometrial Endometroid and Ovarian Cancers.子宫内膜样癌和卵巢癌中人乳头瘤病毒(HPV16/18)、爱泼斯坦-巴尔病毒(EBV)及人巨细胞病毒(HCMV)的检测与基因分型
Pathogens. 2023 Mar 1;12(3):397. doi: 10.3390/pathogens12030397.
10
Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study.血小板 RNA 可准确检测卵巢癌:一项洲际生物标志物识别研究。
Protein Cell. 2023 Jun 7;14(6):579-590. doi: 10.1093/procel/pwac056.